
Novacyt Investor Relations Material
Latest events

H2 2024
Novacyt
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Novacyt S.A.
Access all reports
Novacyt S.A. is a biotechnology company focused on the development, manufacturing, and commercialization of clinical diagnostic products. It operates primarily through its business units, including Primerdesign, Lab21 Products, and IT-IS International. The company specializes in in vitro and molecular diagnostics, offering a wide range of assays, reagents, and PCR devices for detecting various infectious diseases, including pathogens responsible for respiratory, gastrointestinal, and insect-borne illnesses. Novacyt serves a global market, providing its products to public hospitals, central laboratories, and private testing facilities. The company is headquartered in Camberley, United Kingdom, and its shares are listed on the Euronext Growth.
Key slides for Novacyt S.A.


H2 2024
Novacyt S.A.


H1 2024
Novacyt S.A.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
ALNOV
Country
🇫🇷 France